Elsevier, Journal of Pediatrics, 6(165), p. 1252-1254, 2014
DOI: 10.1016/j.jpeds.2014.08.010
Full text: Download
Effects on linear growth were noted in children treated with peginterferon ± ribavirin in the Pediatric Study of Hepatitis C trial. Growth was further examined in a subset of patients followed for up to 6 years post-treatment. No long-term effects on height-for-age z scores were observed that could be attributed to hepatitis C virus treatment.